장마감
로그인 회원가입
CHE
CHE
Chemed Corp
7월 27일 4:00 PM ET (한국 7/28 05:00)
$509.34
-1.79 ▼ -0.35%
🌙 7월 27일 5:05 PM ET (한국 7/28 06:05)
$509.34
+0.00 +0.00%

케메드(CHE) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$6.8B
스몰캡
P/E
27.8
적정 수준
배당수익률
0.48%
52주 위치
95%
저점 +39% · 고점 -2%
애널리스트
보유
B-
Fundamental health
vs. Medical Care Facilities
수익성
Top 10%
성장
Top 53%
밸류에이션
Top 28%
재무 안정
Top 76%
💰 Is this stock pricier than usual right now?
Compared to this company's own recent 3년 (not other companies).
Very cheap
Cheap
Typical
Pricey
Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 19414원. Over the past 3년, it usually traded around 1140원. Roughly in line with its own history.
Pricy doesn't mean bad — it means expectations are already baked in.· based on 2.9 profitable years
Index -P/E 27.76EPS (ttm) 18.35Insider Own 1.85%Shs Outstand 13.2MPerf Week -0.84%
Market Cap 6.76BForward P/E 18.95EPS next Y 10.43%Insider Trans -2.93%Shs Float 13.0MPerf Month 12.4%
Enterprise Value 6.99BPEG 1.86EPS next Q 5.6Inst Own 103.3%Short Float 4.34%Perf Quarter 20.95%
Income 0.26BP/S 2.66EPS this Y 12.96%Inst Trans -3.89%Short Ratio 2.67Perf Half Y 14%
Sales 2.54BP/B 7.94EPS next 5Y 10.21%ROA 15.93%Short Interest 0.57MPerf YTD 19.04%
Book/sh 64.15P/C 401.01EPS past 3/5Y 3.52% -1.2%ROE 25.6%52W High -1.62% ($517.74)Perf Year 8.2%
Cash/sh 1.27P/FCF 17.93Sales past 3/5Y 5.82% 4%ROIC 24.89%52W Low 39.47% ($365.20)Perf 3Y -2.19%
Dividend Est. $2.46 (0.48%)EV/EBITDA 17.74EPS Y/Y TTM -11.26%Gross Margin 29.68%Volatility(W/M) 2.52% 2.42%Perf 5Y 6.07%
Dividend TTM 2.4EV/Sales 2.75Sales Y/Y TTM 2.07%Oper. Margin 12.93%ATR (14) 12.15Perf 10Y 241.88%
Dividend Ex-Date 2026/5/28Quick Ratio 0.83EPS Q/Q -0.35%Profit Margin 10.23%RSI (14) 69.25Recom 2.6
Dividend Gr. 3/5Y 14.13% 10.76%Current Ratio 0.85Sales Q/Q 1.63%SMA20 3.38% ($492.69)Beta 0.5Target Price $474
Payout 11.99%Debt/Eq 0.29Earnings 2026/7/28SMA50 11.03% ($458.74)Rel Volume 0.77Prev Close $511.13
Employees 15811LT Debt/Eq 0.23EPS/Sales Surpr. 6.55% 1.18%SMA200 17.38% ($433.92)Avg Volume(3M) 0.21MPrice $509.34
IPO 1982/6/29Option/Short Yes/YesTrades 4880Volume 163,745Change -0.35%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $658M (YoY +2%) · 순이익 $66M (YoY -8%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Chemed Corp (CHE) Investment Analysis

What kind of company is Chemed Corp?

케메드(CHE) 방어주
Healthcare · Medical Care Facilities
#1186 by Market Cap — Mid-Cap

A US-based company that operates two businesses side by side: hospice (end-of-life care) medical services and plumbing/sewer repair services. It owns two distinctly different businesses — one of the largest hospice operations in the US and a plumbing repair franchise — making it a diversified name whose performance is tied to both aging-driven hospice demand and plumbing service demand. It is also known for paying dividends.

Learn more about Chemed Corp →
Market Cap
$6.8B
Approx. KRW 9.3 trillion
⚖️ 2% of Samsung Electronics
Market Cap Rank1186
Employees15,811people
IPO1982/06/29
Current Price$509.34 ≈ 697,796원
NYSE · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-1
예상 매출 - · EPS $5.60
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🎯 Ex-div 2026년 5월 28일 (목) 주당 $0.6
🔔 Earnings release 2026년 4월 23일 (목) · 장 마감 후 EPS +6.5% 매출 +1.2%
🎯 Ex-div 2026년 2월 23일 (월) 주당 $0.6

Is it profitable?

Profitability healthy
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
12.9%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Care Facilities Median 5.8% · Top 20%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
10.2%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Care Facilities Median 2.5% · Top 10%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
29.7%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Care Facilities Median 19.2% · Top 24%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
25.6%
✓ 우수
My positionTop 25%
Low range Average High range
Healthcare 중형주 Median -17.0% · Top 6%
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
15.9%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 중형주 Median -9.3% · Top tier
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
24.9%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 중형주 Median -11.9% · Top tier
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.29
✓ Healthy debt
My positionMid-range
Low range Average High range
Medical Care Facilities Median 0.92
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
0.85
✓ 부진
My positionBottom 25%
Low range Average High range
Medical Care Facilities Median 1.35
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.83
✓ 평균
My positionMid-range
Low range Average High range
Medical Care Facilities Median 1.19
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$474.00
현재가 대비 -6.9%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
18.95배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
PEG (성장 반영 밸류)
1.86
다소 비쌈
💡 PEG 1.5~2 — 성장 대비 다소 비쌈
내년 EPS 예상 성장률
+10.4%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+10.2%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Reliability
Beat estimates in 1 of the last 1 quarters
1
예상 상회
0
예상 부합
0
예상 하회
100%
상회 비율
+6.6%
평균 서프라이즈
2026.04.23
상회
실적 $5.65 · 예상 $5.30 +6.6%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Strong Growth
Above the industry average, both historically and going forward
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+13.0%
우수
My positionTop 25%
Low range Average High range
방어주 중형주 Median 5.2% · Top 25%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+10.4%
평균
My positionMid-range
Low range Average High range
방어주 중형주 Median 10.7% · Bottom 49%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+10.2%
양호
My positionMid-range
Low range Average High range
방어주 중형주 Median 7.2% · Top 26%
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
+3.5%
평균
My positionMid-range
Low range Average High range
방어주 중형주 Median 4.5% · Bottom 48%
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
-1.2%
평균
My positionMid-range
Low range Average High range
방어주 중형주 Median 6.5% · Bottom 36%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+4.0%
부진
My positionBottom 25%
Low range Average High range
방어주 중형주 Median 7.7% · Bottom 19%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+1.6%
평균
My positionMid-range
Low range Average High range
방어주 중형주 Median 4.6% · Bottom 32%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

Has the stock risen over the long term?

Long-term weakness — -62%p below the market
CHE +6.1% · S&P 500 +68.3%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-62.3%p
Significantly behind the market
vs Health Care (XLV)
-18.4%p
behind the sector average
1-year basis
vs S&P 500
-7.8%p
slightly behind the market
vs Health Care (XLV)
-11.5%p
behind the sector average
Rank among peers
1-year return Bottom 13% Based on 11 peers
Current position within 52-week range
Low (-39.5%p) High (-1.6%p)
Current price is 39.5% above the 52-week low and 1.6% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-23.0%
Annualized volatility
35.5%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 137-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢
Current diagnosis · 2026-07-27
Uptrend zone

Current price $509.34 above the midline ($492.70). Normal upward flow. Above the Ichimoku cloud (bullish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

Current diagnosis · 2026-07-27
Death cross — bearish reversal signal

MACD(15.758) crossed below Signal(16.019). Trend reversal possible; read as a sell entry point.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-27
Bullish zone

RSI 69.3 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 81.5.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

In line with the industry average
Pricey on Vs. Assets·Vs. Sales, In line with peers on Vs. Earnings·Vs. Cash Flow
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Mid-range
🏢 Vs. Assets Pricey
🧾 Vs. Sales Pricey
💧 Vs. Cash Flow Mid-range
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
27.76x
✓ Fair
My positionMid-range
Low range Average High range
Medical Care Facilities median 19.84x · Around the industry average
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
18.95x
✓ Fair
My positionMid-range
Low range Average High range
Medical Care Facilities median 18.77x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
7.94x
✓ Pricey
My positionBottom 25%
Low range Average High range
Medical Care Facilities median 2.69x · Bottom 12% — expensive within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
2.66x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Medical Care Facilities median 0.92x · Bottom 1% — expensive within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
17.74x
✓ Fair
My positionMid-range
Low range Average High range
Medical Care Facilities median 11.60x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
17.93x
✓ Fair
My positionMid-range
Low range Average High range
Medical Care Facilities median 14.23x · Around the industry average
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$474.00 vs. current price -6.9%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Care Facilities

Who owns it?

Ownership backdrop is unfavorable
Insider modest net selling -2.9% · Institutional net selling -3.9% · Short interest light 4.3% · Short interest up +0.9pp over last 90d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-2.9%
Insiders net selling
🏦 Institutions (funds & investors)
-3.9%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 103.3%
Institution-led, stable structure
Healthcare 중형주 Median 89.4%
🧑‍💼 Insiders 1.9%
Typical level
Healthcare 중형주 Median 9.4%
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
4.3%
Low — limited short-side pressure
Healthcare 중형주 Median 11.3%
Past 90 days 📈 +0.9%p increase
Short interest days to cover
2.7 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 13.2M주
Float (tradable shares) 13.0M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding CHE

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당 지급 — 연 0.48%
배당보다 주가 성장에 가까운 비중
Dividend Yield
0.48%
Industry average 1.23%
Dividend Per Share
$2.46
Annualized
Payout Ratio
12%
Share of net income paid as dividends
5-Year Growth
10.8%
Annualized dividend growth
🏆 17년 연속 배당 증가
📅 지급월 2월 · 8월 · 11월
📊 총 이력 1988~2026 (150건)
연도별 배당 총액 추이
주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.
$1.00 +8.7%
2016
$1.08 +8.0%
2017
$1.16 +7.4%
2018
$1.24 +6.9%
2019
$1.32 +6.5%
2020
$1.40 +6.1%
2021
$1.48 +5.7%
2022
$1.56 +5.4%
2023
$1.80 +15.4%
2024
$2.20 +22.2%
2025
$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소
최근 배당 이력 총 150건
아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.
배당락일
주당 금액
지급일
당시 수익률
2026-02-23
$0.600
0.59%
2025-11-17
$0.600
0.62%
2025-08-11
$0.600
0.60%
2025-05-29
$0.500
0.42%
2025-02-24
$0.500
0.35%
2024-11-18
$0.500
0.32%
2024-08-12
$0.500
0.30%
2024-05-30
$0.400
0.29%
2024-02-23
$0.400
0.33%
2023-11-10
$0.400
0.33%
2023-08-11
$0.400
0.37%
2023-05-24
$0.380
0.35%
2023-02-24
$0.380
0.35%
2022-11-10
$0.380
0.37%
2022-08-12
$0.380
0.37%
2022-05-25
$0.360
0.36%
2022-02-25
$0.360
0.37%
2021-11-12
$0.360
0.35%
2021-08-13
$0.360
0.38%
2021-05-26
$0.340
0.34%
2021-02-26
$0.340
0.37%
2020-11-13
$0.340
0.27%
2020-08-14
$0.340
0.26%
2020-05-27
$0.320
0.33%
2020-02-28
$0.320
0.37%
2019-11-07
$0.320
0.38%
2019-08-09
$0.320
0.35%
2019-05-29
$0.300
0.45%
2019-03-01
$0.300
0.36%
2018-11-08
$0.300
0.44%
2018-08-10
$0.300
0.45%
2018-05-30
$0.280
0.34%
2018-02-23
$0.280
0.52%
2017-11-10
$0.280
0.47%
2017-08-10
$0.280
0.69%
2017-05-23
$0.260
0.63%
2017-02-23
$0.260
0.71%
2016-11-09
$0.260
0.89%
2016-08-11
$0.260
0.87%
2016-05-24
$0.240
0.89%
2016-02-25
$0.240
0.89%
2015-11-12
$0.240
0.78%
2015-08-13
$0.240
0.76%
2015-05-26
$0.220
0.88%
2015-02-26
$0.220
0.91%
2014-11-13
$0.220
0.96%
2014-08-14
$0.220
0.80%
2014-05-27
$0.200
1.10%
2014-02-27
$0.200
1.13%
2013-11-14
$0.200
1.25%
2013-08-08
$0.200
1.28%
2013-05-28
$0.180
1.29%
2013-02-28
$0.180
0.91%
2012-11-15
$0.180
1.07%
2012-08-09
$0.180
1.33%
2012-05-29
$0.160
1.13%
2012-02-23
$0.160
1.22%
2011-11-15
$0.160
1.29%
2011-08-16
$0.160
1.03%
2011-05-24
$0.140
1.03%
2011-02-24
$0.140
1.03%
2010-11-18
$0.140
0.86%
2010-08-12
$0.140
1.20%
2010-05-25
$0.120
0.94%
2010-02-25
$0.120
0.89%
2009-11-17
$0.120
0.91%
2009-08-13
$0.120
0.82%
2009-06-04
$0.060
0.60%
2009-02-26
$0.060
0.59%
2008-11-19
$0.060
0.79%
2008-08-18
$0.060
0.66%
2008-05-27
$0.060
0.83%
2008-02-22
$0.060
0.58%
2007-11-23
$0.060
0.45%
2007-08-20
$0.060
0.42%
2007-05-29
$0.060
0.36%
2007-02-22
$0.060
0.63%
2006-11-20
$0.060
0.65%
2006-08-18
$0.060
0.75%
2006-05-24
$0.060
0.57%
2006-02-27
$0.060
0.42%
2005-11-18
$0.060
0.63%
2005-08-18
$0.060
0.73%
2005-05-25
$0.060
0.71%
2005-02-25
$0.060
0.66%
2004-11-18
$0.060
0.78%
2004-08-18
$0.060
1.14%
2004-05-26
$0.060
1.28%
2004-02-17
$0.060
0.76%
2003-11-18
$0.060
1.75%
2003-08-19
$0.060
1.60%
2003-05-28
$0.060
1.56%
2003-02-14
$0.060
1.71%
2002-11-18
$0.060
1.53%
2002-08-19
$0.055
1.28%
2002-05-28
$0.055
1.54%
2002-02-19
$0.055
1.23%
2001-11-20
$0.055
1.52%
2001-08-15
$0.055
1.66%
2001-05-30
$0.055
1.46%
2001-02-14
$0.055
1.46%
2000-11-15
$0.050
2.74%
2000-08-16
$0.050
4.47%
2000-05-31
$0.050
4.16%
2000-02-16
$0.050
7.61%
1999-11-17
$0.265
10.63%
1999-08-18
$0.265
8.41%
1999-05-28
$0.265
8.17%
1999-02-17
$0.265
8.55%
1998-11-18
$0.265
8.46%
1998-08-19
$0.265
8.27%
1998-05-29
$0.265
7.14%
1998-02-18
$0.265
6.50%
1997-11-19
$0.265
6.43%
1997-08-20
$0.260
7.12%
1997-05-29
$0.260
5.68%
1997-02-19
$0.260
7.07%
1996-11-20
$0.260
5.70%
1996-08-20
$0.260
5.44%
1996-05-23
$0.260
5.46%
1996-02-20
$0.260
5.36%
1995-11-20
$0.260
5.68%
1995-08-16
$0.260
5.94%
1995-05-22
$0.255
7.73%
1995-02-15
$0.255
8.00%
1994-11-17
$0.255
7.73%
1994-08-15
$0.255
7.47%
1994-05-23
$0.255
7.41%
1994-02-15
$0.255
8.00%
1993-11-17
$0.255
7.81%
1993-08-16
$0.250
6.37%
1993-05-24
$0.250
6.81%
1993-02-16
$0.250
7.11%
1992-11-17
$0.250
9.52%
1992-08-14
$0.250
6.56%
1992-05-22
$0.250
9.10%
1992-02-14
$0.250
7.30%
1991-11-18
$0.250
7.88%
1991-08-14
$0.245
12.25%
1991-05-24
$0.245
11.14%
1991-02-13
$0.245
10.59%
1990-11-16
$0.245
12.02%
1990-08-15
$0.245
9.56%
1990-05-25
$0.245
6.82%
1990-02-14
$0.245
7.06%
1989-11-16
$0.230
6.39%
1989-08-16
$0.230
4.75%
1989-05-23
$0.230
3.82%
1989-02-15
$0.230
2.68%
1988-11-17
$0.215
1.42%
* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.
💰 내가 100만원 투자한다면
연간 배당금 (세후) 4,105원
5년 누적 (세후) 2.5만원
* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 10.76% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
CHE CHE This Stock
$6.8B27.8 7.9 25.6% 0.48% -0.3%
LLY
$1.13T43.1 36.2 107.64% 0.58% +0.1%
JNJ
$640.9B30.8 7.5 25.74% 2.02% +1.0%
ABBV
$453.9B126.7 - 15221.82% 2.67% -0.9%
UNH
$379.3B26.9 3.9 12.49% 2.16% -0.7%
MRK
$323.0B36.8 7.0 18.97% 2.5% -0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen

FAQ

What kind of company is 케메드(CHE)?

케메드(CHE) belongs to the Healthcare sector and operates in the Medical Care Facilities industry.

What is the market cap of CHE?

The market cap of CHE is approximately $6.8B, ranking 1,186 within its sector.

Does CHE pay dividends?

CHE has a dividend yield of approximately 0.48%, with an annual dividend of $2.46.

What is the P/E ratio of CHE?

CHE has a P/E ratio of approximately 27.8x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for CHE?

CHE has recorded a 52-week high of $517.74 and a low of $365.20.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.